Newsfeeds Archive - Spark Newswire

4 minute read

Lineage Cell Therapeutics Announces OpRegen Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured At 2024 Retinal Cell & Gene Therapy Innovation Summit

May 6, 8:04 AM

BCVA gains of +5.5 letters at 24 months in Cohort 4 patients (n=10)BCVA gains of +7.4 letters among Cohort 4 patients with extensive OpRegen bleb coverage of the GA lesion (n=5)Maintenance or increases in external

LCTX

1 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Pre-Market Session

By Benzinga Insights

February 14, 9:05 AM

Gainers Cogent Biosciences (NASDAQ:COGT) shares rose 45.6% to $7.95 during Wednesday’s pre-market session. The company’s market cap stands…

ALLK

2 minute read

Lineage Cell Therapeutics Announces $14M Million Registered Direct Offering

By Benzinga Newsdesk

February 6, 10:17 AM

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that it entered into a definitive

LCTX

1 minute read

Movers

12 Health Care Stocks Moving In Thursday’s After-Market Session

By Benzinga Insights

February 1, 5:31 PM

Gainers MyMD Pharmaceuticals (NASDAQ:MYMD) shares increased by 9.3% to $0.15 during Thursday’s after-market session. The market value of…

ADAG

1 minute read

Lineage Cell Therapeutics, Inc. Announces RG6501 Phase 1/2a Results Will Be Featured At 2024 Angiogenesis Exudation And Degeneration Meeting In Presentation By Allen Ho, MD, FACS, FASRS

By Benzinga Newsdesk

January 16, 9:23 AM

LCTX

2 minute read

Lineage Cell Therapeutics, Longeveron And 2 Other Stocks Under $2 Insiders Are Buying

By Avi Kapoor

January 3, 8:11 AM

The Dow Jones index closed higher by around 25 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

AISP

1 minute read

Movers

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

December 29, 9:05 AM

Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) stock rose 154.2% to $5.11 during Friday’s pre-market session. The market value of…

BBLG

1 minute read

Earnings

Lineage Cell Therapeutics: Q3 Earnings Insights

By Benzinga Insights

November 9, 5:35 PM

Lineage Cell Therapeutics (AMEX:LCTX) reported its Q3 earnings results on Thursday, November 9, 2023 at 04:01 PM. Here’s…

LCTX

22 minute read

Earnings

Earnings Scheduled For November 9, 2023

By Benzinga Insights

November 9, 7:52 AM

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.

AAOI

1 minute read